Ludvik Sandnes, Nordic Nanovector interim CEO (L) and Alf Bjørseth, Thor Medical CEO

June 9, 2023 10:52 AM EDT

Oslo biotech finds another merger partner after shareholders rejected November offer

Kyle LaHucik

Senior Reporter

Shareholders of Nordic Nanovector did not like the first merger partner the Norwegian biotech chose last fall. So the company went back to the drawing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Oslo biotech finds another merger partner after shareholders rejected November offer

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

New fund will pressure flailing biotechs, as investor frustration boils over

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Oslo biotech finds an­oth­er merg­er part­ner af­ter share­hold­ers re­ject­ed No­vem­ber of­fer

Senior Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Oslo biotech finds another merger partner after shareholders rejected November offer